Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery

被引:32
|
作者
Al Harakeh, Ayman B. [3 ]
Burkhamer, Kyle J. [2 ]
Kallies, Kara J. [2 ]
Mathiason, Michelle A. [2 ]
Kothari, Shanu N. [1 ]
机构
[1] Gundersen Lutheran Hlth Syst, Dept Gen Surg, La Crosse, WI 54601 USA
[2] Gundersen Lutheran Med Fdn, Dept Surg Res, La Crosse, WI USA
[3] Gundersen Lutheran Med Fdn, Dept Med Educ, La Crosse, WI USA
关键词
Laparoscopic gastric bypass; Insurance; Denial; Co-morbidities; Morbid obesity; GASTROESOPHAGEAL-REFLUX DISEASE; Y GASTRIC BYPASS; WEIGHT-LOSS; SURVIVAL; DENIALS; IMPACT;
D O I
10.1016/j.soard.2010.08.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients satisfying the National Institutes of Health criteria and deemed appropriate candidates often do not undergo bariatric surgery for insurance-related reasons. Our objective was to explore the natural history of these patients compared with that of those who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB). Methods: The medical records of the patients evaluated for LRYGB from 2001 to 2007 were retrospectively reviewed. The presence of co-morbidities was assessed at the initial evaluation and within a 3-year follow-up period for patients who had undergone LRYGB and those denied surgery. The statistical analysis included chi-square tests. Results: A total of 189 patients were in the denied cohort and 587 in the LRYGB cohort. The age, gender, and body mass index were similar between the 2 cohorts at the initial evaluation. The percentage of patients with a diagnosis of a co-morbidity in the denied and LRYGB cohorts at the initial evaluation was 20% and 25% with diabetes mellitus, 51% and 43% with hypertension, 20% and 22% with obstructive sleep apnea, 34% and 24% with lipid disorders, and 62% and 49% with gastroesophageal reflux disease, respectively. The body mass index at the initial evaluation and during follow-up was 47.3 and 46.8 kg/m(2) in the denied cohort (n = 165, P = .236) and 48.5 and 30.5 kg/m(2) in the LRYGB cohort (n = 544, P < .001), respectively. During the follow-up period, a greater incidence of new-onset diabetes (P < .001), hypertension (P < .001), obstructive sleep apnea (P < .001), gastroesophageal reflux disease (P < .001), and lipid disorders (P < .001) was observed in the denied cohort. Conclusion: Patients denied LRYGB had a greater incidence of new co-morbidities diagnosed within a short follow-up period, without a significant change in their body mass index. (Surg Obes Relat Dis 2010;6:591-596.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 50 条
  • [1] Bariatric Surgery for Morbid Obesity
    Mark J Monteforte
    Charles M Turkelson
    Obesity Surgery, 2000, 10 : 391 - 401
  • [2] Bariatric surgery for treatment of morbid obesity in adults
    Park, Ki Bum
    Jun, Kyong-Hwa
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2025, 40 (01) : 24 - 39
  • [3] Genetic Obesity and Bariatric Surgery Outcome in 1014 Patients with Morbid Obesity
    Cooiman, M. I.
    Kleinendorst, L.
    Aarts, E. O.
    Janssen, I. M. C.
    van Amstel, H. K. Ploos
    Blakemore, A. I.
    Hazebroek, E. J.
    Meijers-Heijboer, H. J.
    van der Zwaag, B.
    Berends, F. J.
    van Haelst, M. M.
    OBESITY SURGERY, 2020, 30 (02) : 470 - 477
  • [4] Preparation for bariatric surgery for patients with morbid obesity
    Sierzantowicz, Regina
    Hady, Hady Razak
    Kirpsza, Bozena
    Trochimowicz, Lech
    Dadan, Jacek
    PIELEGNIARSTWO CHIRURGICZNE I ANGIOLOGICZNE-SURGICAL AND VASCULAR NURSING, 2012, (03): : 105 - 108
  • [5] Bariatric Surgery: Effects on the Metabolic Complications of Obesity
    Clifton, Peter M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2012, 14 (02) : 95 - 100
  • [6] Reproductive Function in Patients with Morbid Obesity after Bariatric Surgery
    Sosnovskikh, Ekaterina Viktorovna
    Rubtsov, Dmitry Andreevich
    Stepanova, Natalya Yurievna
    Kruchinin, Evgeny Viktorovich
    Autlev, Kazbek Medzhidovich
    JOURNAL OF BIOCHEMICAL TECHNOLOGY, 2021, 12 (01) : 63 - 66
  • [7] Bariatric surgery for morbid obesity
    Monteforte, MJ
    Turkelson, CM
    OBESITY SURGERY, 2000, 10 (05) : 391 - 401
  • [8] Morbid obesity and dyslipidaemia: The impact of bariatric surgery
    Climent, Elisenda
    Benaiges, David
    Goday, Albert
    Villatoro, Montserrat
    Julia, Helena
    Ramon, Jose M.
    Flores, Juana A.
    Pedro-Botet, Juan
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2020, 32 (02): : 79 - 86
  • [9] Impact of Bariatric Surgery on the Saliva of Patients with Morbid Obesity
    Lina N. Hashizume
    Lucelen F. Bastos
    Débora D. Cardozo
    Juliana B. Hilgert
    Fernando N. Hugo
    Airton T. Stein
    Kátia E. P. Souto
    Nelson G. Meinhardt
    Obesity Surgery, 2015, 25 : 1550 - 1555
  • [10] Impact of Bariatric Surgery on the Saliva of Patients with Morbid Obesity
    Hashizume, Lina N.
    Bastos, Lucelen F.
    Cardozo, Debora D.
    Hilgert, Juliana B.
    Hugo, Fernando N.
    Stein, Airton T.
    Souto, Katia E. P.
    Meinhardt, Nelson G.
    OBESITY SURGERY, 2015, 25 (08) : 1550 - 1555